YOU SEARCHED BY...
Contract Service Directory
CPL
Company Headquarters
7600 Danbro Crescent
Mississauga, ON L5N6L6
Canada
Company Description
CPL is a leading contract development and manufacturing organization (CDMO) providing product development services and commercial manufacturing of non-sterile liquid and semi-solid pharmaceutical products. Our modern development, manufacturing and testing facilities are registered and audited with the FDA and Health Canada and have a solid record of regulatory compliance. Our product experience includes NDA's, ANDA's, 505b2, and OTC products, and we provide clinical trial materials through commercial product manufacturing. CPL has completed substantial investments in new filling and manufacturing technologies including new Symex mixing vessels and new tube and bottle filling capabilities. From product development to commercial production, CPL provides turnkey solutions to our customers all under one company.
Contract Service Directory
- Contract Development and Manufacturing Organization (CDMO)
- Contract Manufacturing
- Formulation Development
- In Vitro Testing
- Manufacturing, Clinical Trials Supply
- Manufacturing, Creams & Ointments
- Manufacturing, Dose Form, Non-Sterile
- Manufacturing, Gels
- Manufacturing, Generics
- Manufacturing, Liquids
- Manufacturing, Nasal Delivery
- Manufacturing, OTC
- Manufacturing, Solutions & Suspensions
- Manufacturing, Topicals
- Packaging, Creams & Ointments
- Packaging, Liquids
- Preformulation
- Process Development/Scale-Up Services
- Scale-Up
Contract Services Directory
Related Content
-
THE CENTRE FOR CELL AND VECTOR PRODUCTION (CCVP)
A Transparent and Flexible Approach to Manufacturing
-
Breaking News | CRO News | Promotions & Moves
Parexel Adds Experts to Regulatory Consulting Group
Four new hires from U.S. FDA and MHRA will serve as technical vice presidents12.10.19
-
Breaking News | Drug Development | Trials & Filings
SK Bio Gains FDA Approval for XCOPRI
Marks the first time a Korean company has independently brought a compound from discovery to U.S. FDA approval11.25.19
-
Biologics, Proteins, Vaccines | Biosimilars
Biopharma Over 20 Years
A look at the key trends that have impacted the biopharma industry over the years.K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19
-
CPL's David Tyler
CPL's director of business development was on hand at Contract Pharma 2019.Contract Pharma
-
-
Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!
Contracting & Outsourcing 2019 featured a sold-out exhibit hall and lively conference sessions.10.22.19
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
FPP Inks ANDA Generic Deal
Upon approval, manufacturing will be performed by the CDMO Novocol.10.21.19
-
Breaking News
Contract Pharma’s 18th Conference & Tabletop Exhibit Was a Another Success!
Contracting & Outsourcing 2019 featured a sold-out exhibit hall and lively conference sessions.10.18.19
-
Breaking News | Industry News
VIDEO: CPL's David Tyler
CPL's director of business development was on hand at Contract Pharma 2019.10.04.19
-
VIDEO: Contract Pharma 2019 Video Highlights!
Contracting & Outsourcing 2019 featured a sold-out exhibit hall and lively conference sessions.10.02.19
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Injectables
Pii to Manufacture FDA-Approved Hormone Therapy Injection Drug Product
ANDA holder Sagent will sell, market and distribute the drug product in the U.S.09.23.19
-
-
Regulatory Affairs
Quality Metrics Feedback
A look at FDA’s Quality Metrics Initiative, a complicated issue for all of pharma stakeholdersGil Roth, President, Pharma & Biopharma Outsourcing Association 09.16.19
-
Breaking News | Clinical Trials | Industry News | Inspections | QA/QC
FDA Extends CRADA with CluePoints
Aims to further explore a data-driven approach to quality oversight in clinical trials09.11.19
-
cGMP Manufacture | Collaborations & Alliances
NIIMBL, FDA to Advance Innovation in Bio Manufacturing
CRADA enables FDA and NIIMBL to support investments in regulatory science research, and training needed to foster advanced manufacturing innovations08.01.19
-
cGMP Manufacture | Industry News | Regulatory Affairs
FDA Posts FY2020 GDUFA Fees
The fee for U.S. CMO FDF facilities will drop 7% next year; negotiation efforts led by PBOA07.25.19
-
Trials & Filings
FDA Accepts RedHill Biopharma’s NDA for Talicia
Commercial launch of H. pylori treatment is planned shortly following potential FDA approval07.16.19
-
Extractables and Leachables | Laboratory Testing
The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?
Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standardsKristin Brooks, Contract Pharma 07.11.19
-
SunGen Pharma, Athenex Pharma Partner for Bivalirudin Launch
An anticoagulant injection with 2018 US Market Sales at $81.8M according to IQVIA data06.27.19
-
Trials & Filings
Sierra’s Momelotinib Granted FDA Fast Track Designation
Underscores potential for momelotinib to address unmet needs of patients with Intermediate/High-Risk myelofibrosis who have previously received a JAK inhibitor06.19.19
-
Bio News | cGMP Manufacture | Drug Development | Industry News
CPL Details Full-Service Offerings
David Tyler, Director of Business Development, spoke with Contract Pharma at the Contracting & Outsourcing 2018 Conference
-
WHO Lauds India’s Vaccine Safety
The World Health Organization endorses India’s regulation of vaccines even as desi players try their hands in more advanced vS. Harachand, Contributing Editor 04.03.17
-
Breaking News | Clinical Trial Materials | Formulation Development | Promotions & Moves | Validation
-
Biosimilars | Clinical Trials | R&D
-
Breaking News | Drug Development | Industry News
CPL Ltd. To Close Buffalo Facility
260 employees to be laid off as CPL consolidates operations.05.24.10
-
Breaking News | Formulation Development | Industry News | Logistics
-
Capsules | Injectables | QA/QC
